Organogenesis Holdings Inc (ORGO)

NASDAQ HEALTHCARE

$2.35 +0.86% RSI 38 Neutral Add Alert

Moving Averages

SMA 200

$4.25

Price below

Company Profile

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports medicine markets in the United States. The company is headquartered in Canton, Massachusetts.

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Market Cap

$306.17M

P/E Ratio

15.87

EPS

$0.15

Beta

1.48